Home›Companies›Biotech & Pharma›Outpace Bio

Outpace Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 1, 2024·Suggest an edit

About Outpace Bio

Outpace Bio is a private company based in Seattle, Washington, incorporated in 2020 in Delaware. It has reported $55,999,992 raised in one offering on Form D since August 2024. Its chief executive is Marc Lajoie.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 17, 2024Aug 1, 2024$55,999,992of $144.2M target25$2.2MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Outpace Bio's Form D filed Aug 1, 2024.

JS
Jake Simson
Director
AF
Aaron Foster
Executive officer
BJ
VB
CS
Charity Scripture
Executive officer
SB
Scott Boyken
Executive officer, director and promoter
ES
Eric Soller
Executive officer
ML
Marc Lajoie
Chief Executive Officer and director

Sources

  1. SECOutpace Bio, Inc. filing history